At what gestational age range should antenatal betamethasone be administered to pregnant women at risk of preterm delivery?

Antenatal Betamethasone Gestational Age

Administer antenatal betamethasone to pregnant women at risk of preterm delivery between 24 0/7 and 36 6/7 weeks of gestation, with the strongest evidence supporting use from 24 0/7 to 33 6/7 weeks (standard indication) and conditional use from 34 0/7 to 36 6/7 weeks (late preterm) when delivery is expected within 7 days. 1, 2, 3, 4

Standard Gestational Age Window (24 0/7 to 33 6/7 weeks)

A single course of betamethasone is strongly recommended for all pregnant women between 24 0/7 and 33 6/7 weeks of gestation who are at risk of preterm delivery within 7 days. 3, 4 This represents the standard of care with the most robust evidence for benefit. 3

• This recommendation applies to singleton and multiple gestations, as well as pregnancies with ruptured membranes. 3, 4
• Administration may be considered as early as 23 0/7 weeks based on family decisions regarding resuscitation, irrespective of membrane status and fetal number. 3, 4

Late Preterm Window (34 0/7 to 36 6/7 weeks)

For singleton pregnancies between 34 0/7 and 36 6/7 weeks, betamethasone should be offered when there is a high probability of delivery within 7 days and before 37 weeks, provided the patient does not have pregestational diabetes. 1, 2 This is a GRADE 1A recommendation from the Society for Maternal-Fetal Medicine. 1

High-Risk Criteria for Late Preterm Administration

The patient must meet at least one of the following criteria to qualify for late preterm steroids: 1

• Preterm labor with intact membranes and cervical dilation ≥ 3 cm, or
• Cervical effacement ≥ 75%, or
• Preterm premature rupture of membranes (PPROM), or
• Planned preterm delivery for maternal or fetal indications within 24 hours to 7 days

Absolute Contraindications

• Pregestational diabetes mellitus (type 1 or type 2) – This is an absolute contraindication due to markedly increased risk of severe neonatal hypoglycemia. 1, 2
• Low probability of delivery before 37 weeks – Steroids should be withheld when delivery is unlikely within the treatment window. 1, 2

Dosing Regimen (All Gestational Ages)

Administer betamethasone 12 mg intramuscularly as two doses given 24 hours apart, using the dual-salt formulation (betamethasone sodium phosphate + betamethasone acetate). 1, 2, 5 This is the only regimen supported by high-quality evidence. 1, 2

• Route: Intramuscular injection only; other routes are not recommended. 2
• Single course only in the late preterm period (34-36 weeks) – repeat courses are not supported. 1

Repeat or Rescue Courses (<34 weeks only)

For women less than 34 0/7 weeks of gestation, a single repeat course should be considered if delivery is imminent within 7 days and the prior course was administered more than 14 days previously. 3, 4

• Rescue courses may be given as early as 7 days after the prior dose if clinically indicated. 3, 4
• This recommendation does not apply to the late preterm period (34-36 weeks). 1

Expected Benefits by Gestational Age

Late Preterm (34-36 weeks)

The ALPS trial demonstrated modest but significant respiratory benefits: 1, 6

• Reduction in need for respiratory support: 14.4% (placebo) to 11.6% (betamethasone) – absolute risk reduction of approximately 3%. 1, 6
• Reduction in severe respiratory morbidity: 12.1% to 8.1% (RR 0.67; 95% CI 0.53-0.84). 1, 6

The absolute benefit varies substantially by gestational age and planned mode of delivery: 7

• Patients planning cesarean delivery at 34 weeks have the highest baseline risk (39.4% without steroids) and largest absolute benefit (7.4% reduction). 7
• Patients planning vaginal delivery at 36 weeks have low baseline risk (6.9% without steroids) and minimal absolute benefit (1.3% reduction). 7

Earlier Preterm (<34 weeks)

The benefits are more substantial at earlier gestational ages, with greater reductions in respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. 3, 8

Important Risks and Counseling Points

Neonatal Hypoglycemia

• Neonatal hypoglycemia occurs more frequently after late preterm betamethasone administration (24.0% vs 15.0% in placebo; RR 1.60). 1, 6
• However, 93% of cases are mild and resolve within 24 hours without long-term sequelae. 1
• This risk is markedly elevated in pregestational diabetes, which is why it represents an absolute contraindication. 1, 5

Long-Term Outcomes

• Long-term neurodevelopmental outcomes remain uncertain for late preterm steroid exposure, as follow-up data beyond the neonatal period are limited. 1, 9
• Recent childhood follow-up from the ALPS trial showed no differences in pulmonary function or asthma at age 6 years, with slightly lower rates of wheezing in the betamethasone group. 10
• Population-based studies have raised concerns about associations with childhood mental health disorders, though causality is not established. 8

No Increased Infection Risk

• Betamethasone does not increase maternal or neonatal infection rates, even in the setting of PPROM. 1
• Standard antibiotic prophylaxis should continue as indicated. 1

Common Clinical Pitfalls

• Confusing gestational diabetes with pregestational diabetes: Only pregestational diabetes (diagnosed before pregnancy) contraindicates late preterm steroids. 1
• Administering steroids to low-risk patients: Many women who receive late preterm steroids do not deliver within 7 days; strict adherence to high-risk criteria is essential. 9, 7
• Using repeat courses in the late preterm period: Evidence supports only a single 2-dose course between 34-36 weeks. 1
• Delaying administration in PPROM: Steroids should be given promptly, as delivery often occurs within 48-72 hours. 1
• Overestimating benefit at 36 weeks with planned vaginal delivery: The absolute risk reduction is minimal (approximately 1%) in this scenario. 7

Special Populations (Conditional Use – GRADE 2C)

Consider betamethasone administration in the following scenarios, though evidence is weaker: 1

• Multiple gestations reduced to singleton ≥ 14 weeks prior
• Fetuses with congenital anomalies (potential respiratory benefit despite anomaly)
• Anticipated delivery in < 12 hours (short interval may still allow steroid effect)